by Chantelle Janse van Rensburg | Nov 26, 2018 | News
Aspen launches novel ARV Combination: Set to further improve treatment options Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of Emdolten®, a Dolutegravir-based triple combination anti-retroviral...
